Literature DB >> 15246340

Treatment of trigeminal neuralgia.

James K Liu1, Ronald I Apfelbaum.   

Abstract

When medical treatment for trigeminal neuralgia fails or is limited by significant side effects, neurosurgeons need to inform their patients of all the available treatment options. The best treatment for the patient depends on the age of the patient, medical comorbidities, and the risks the patient is willing to assume. We recommend microvascular decompression for younger healthy patients with a longer life expectancy. Percutaneous trigeminal neurolysis remains a useful minimally invasive approach for the older patient and for the patient with medical comorbidities and a shorter life expectancy. The role of stereotactic radiosurgery in the treatment of trigeminal neuralgia will be better defined in the future. Partial sectioning of the trigeminal nerve may be considered in patients who have negative explorations during a microvascular decompression or when other less invasive procedures have failed to provide adequate relief.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246340     DOI: 10.1016/j.nec.2004.03.002

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  12 in total

1.  High-resolution 3D-constructive interference in steady-state MR imaging and 3D time-of-flight MR angiography in neurovascular compression: a comparison between 3T and 1.5T.

Authors:  M Garcia; R Naraghi; T Zumbrunn; J Rösch; P Hastreiter; A Dörfler
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

2.  Advanced age as a contraindication to microvascular decompression for drug-resistant trigeminal neuralgia: evidence of prejudice?

Authors:  Paolo Ferroli; Francesco Acerbi; Massimo Tomei; Giovanni Tringali; Angelo Franzini; Giovanni Broggi
Journal:  Neurol Sci       Date:  2009-10-06       Impact factor: 3.307

3.  Peripheral neurectomy: minimally invasive surgical modality for trigeminal neuralgia in Indian population: a retrospective analysis of 20 cases.

Authors:  Sanjay Chandan; Rajshekhar Halli; Vikrant Dilip Sane
Journal:  J Maxillofac Oral Surg       Date:  2013-04-24

4.  First application of 7-T ultra-high field diffusion tensor imaging to detect altered microstructure of thalamic-somatosensory anatomy in trigeminal neuralgia.

Authors:  John W Rutland; Kuang-Han Huang; Corey M Gill; Dillan F Villavisanis; Judy Alper; Gaurav Verma; Joshua B Bederson; Bradley N Delman; Raj K Shrivastava; Priti Balchandani
Journal:  J Neurosurg       Date:  2019-08-30       Impact factor: 5.115

Review 5.  Clinical presentation of trigeminal neuralgia and the rationale of microvascular decompression.

Authors:  Francesco Tomasello; Concetta Alafaci; Filippo Flavio Angileri; Amedeo Calisto; Francesco Maria Salpietro
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

6.  Peripheral neurectomy: a minimally invasive treatment for trigeminal neuralgia. A retrospective study.

Authors:  S M Agrawal; Deepashri H Kambalimath
Journal:  J Maxillofac Oral Surg       Date:  2011-05-06

7.  Complete neuroendoscopic versus microscopical trigeminal neuralgia microvascular decompression (MVD) in primary trigeminal neuralgia (PTN).

Authors:  Peng Wang; Qing Li; Chunsheng Wang; Chunhui Li
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 8.  Advances in diagnosis and treatment of trigeminal neuralgia.

Authors:  Nicola Montano; Giulio Conforti; Rina Di Bonaventura; Mario Meglio; Eduardo Fernandez; Fabio Papacci
Journal:  Ther Clin Risk Manag       Date:  2015-02-24       Impact factor: 2.423

9.  Peripheral Neurectomy for Trigeminal Neuralgia: A Report of Seventeen Cases and Review of the Literature.

Authors:  Mohamed Ragab Nagy; Bokhary Mahmoud
Journal:  Asian J Neurosurg       Date:  2021-05-28

Review 10.  Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view.

Authors:  Jan Vesper; B Bölke; C Wille; P A Gerber; C Matuschek; M Peiper; H J Steiger; W Budach; G Lammering
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.